Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verona Pharma PlcADS | 6,563,340 | 5,507,591 | -1,055,749 | $416.71M | $520.91M | 19.55% | +$104.20M |
| Ascendis Pharma A/SADR(ASND) | 0 | 963,886 | +963,886 | $0 | $166.37M | 6.24% | +$166.37M |
| Arcellx Inc COMMON STOCK | 2,926,478 | 2,478,000 | -448,478 | $191.98M | $163.18M | 6.12% | -$28.80M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 2,548,445 | 2,418,299 | -130,146 | $134.99M | $152.81M | 5.73% | +$17.82M |
| Nuvalent Inc | 1,633,968 | 1,375,180 | -258,788 | $115.88M | $104.93M | 3.94% | -$10.95M |
| Artivion, Inc.(AORT) | 2,793,703 | 2,793,703 | 0 | $68.67M | $86.88M | 3.26% | +$18.21M |
| MeiraGTx Holdings plc(MGTX) | 12,581,103 | 12,626,103 | +45,000 | $85.25M | $82.23M | 3.09% | -$3.02M |
| Insmed Incorporated(INSM) | 509,300 | 650,252 | +140,952 | $38.85M | $65.44M | 2.46% | +$26.59M |
| Edgewise Therapeutics, Inc.(EWTX) | 6,547,328 | 4,639,949 | -1,907,379 | $144.04M | $60.83M | 2.28% | -$83.21M |
| Protagonist Therapeutics Inc | 1,091,271 | 1,074,448 | -16,823 | $52.77M | $59.38M | 2.23% | +$6.61M |
| Solid Biosciences Inc | 11,906,646 | 11,906,646 | 0 | $44.05M | $57.99M | 2.18% | +$13.93M |
| Apogee Therapeutics Inc | 1,122,767 | 1,182,148 | +59,381 | $41.95M | $51.34M | 1.93% | +$9.39M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 7,874,348 | 7,902,365 | +28,017 | $27.88M | $50.65M | 1.90% | +$22.78M |
| Immatics N.V.SHS(IMTX) | 9,383,456 | 9,383,456 | 0 | $42.32M | $50.48M | 1.89% | +$8.16M |
| Akero Therapeutics Inc | 792,960 | 915,887 | +122,927 | $32.10M | $48.87M | 1.83% | +$16.77M |
| Omada Health, Inc.(OMDA) | 0 | 2,426,330 | +2,426,330 | $0 | $44.40M | 1.67% | +$44.40M |
| Amicus Therapeutics Inc COM | 21,464,527 | 7,412,830 | -14,051,697 | $175.15M | $42.48M | 1.59% | -$132.68M |
| Roivant Sciences Ltd.SHS(ROIV) | 0 | 3,331,465 | +3,331,465 | $0 | $37.55M | 1.41% | +$37.55M |
| Merus N V | 690,485 | 708,176 | +17,691 | $29.06M | $37.25M | 1.40% | +$8.19M |
| Soleno Therapeutics Inc | 1,506,602 | 430,439 | -1,076,163 | $107.65M | $36.06M | 1.35% | -$71.58M |
| Astria Therapeutics Inc | 6,485,420 | 6,485,420 | 0 | $34.63M | $34.76M | 1.30% | +$129.7K |
| Immunovant, Inc.(IMVT) | 2,844,072 | 2,137,890 | -706,182 | $48.61M | $34.21M | 1.28% | -$14.40M |
| Neurocrine Biosciences, Inc.(NBIX) | 100,050 | 255,050 | +155,000 | $11.07M | $32.06M | 1.20% | +$20.99M |
| Praxis Precision Medicines, Inc.(PRAX) | 980,894 | 752,921 | -227,973 | $37.15M | $31.66M | 1.19% | -$5.49M |
| Boston Scientific Corporation(BSX) | 130,000 | 280,000 | +150,000 | $13.11M | $30.07M | 1.13% | +$16.96M |
| Caris Life Sciences, Inc.(CAI) | 0 | 1,098,163 | +1,098,163 | $0 | $29.34M | 1.10% | +$29.34M |
| Intuitive Surgical, Inc.(ISRG) | 40,619 | 45,119 | +4,500 | $20.12M | $24.52M | 0.92% | +$4.40M |
| Adma Biologics Inc | 1,373,233 | 1,303,468 | -69,765 | $27.24M | $23.74M | 0.89% | -$3.51M |
| Beta Bionics, Inc.(BBNX) | 1,593,608 | 1,593,608 | 0 | $19.51M | $23.20M | 0.87% | +$3.70M |
| Spyre Therapeutics, Inc.(SYRE) | 2,313,272 | 1,529,445 | -783,827 | $37.32M | $22.90M | 0.86% | -$14.43M |
| Evolus, Inc.(EOLS) | 4,129,142 | 2,474,843 | -1,654,299 | $49.67M | $22.79M | 0.86% | -$26.88M |
| Celcuity Inc.(CELC) | 2,362,279 | 1,633,208 | -729,071 | $23.88M | $21.80M | 0.82% | -$2.08M |
| Dyne Therapeutics, Inc.(DYN) | 2,313,403 | 2,247,390 | -66,013 | $24.20M | $21.40M | 0.80% | -$2.80M |
| Sionna Therapeutics, Inc.(SION) | 1,251,101 | 1,216,045 | -35,056 | $13.09M | $21.10M | 0.79% | +$8.01M |
| Axsome Therapeutics, Inc.(AXSM) | 355,107 | 198,534 | -156,573 | $41.42M | $20.72M | 0.78% | -$20.69M |
| Repligen Corporation(RGEN) | 129,801 | 166,000 | +36,199 | $16.52M | $20.65M | 0.77% | +$4.13M |
| Insulet Corporation(PODD) | 71,597 | 60,387 | -11,210 | $18.80M | $18.97M | 0.71% | +$170.3K |
| Outset Medical, Inc.(OM) | 833,333 | 833,333 | 0 | $9.22M | $16.01M | 0.60% | +$6.79M |
| Zymeworks Inc.(ZYME) | 1,864,672 | 1,275,274 | -589,398 | $22.21M | $16.00M | 0.60% | -$6.20M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 6,993,646 | +6,993,646 | $0 | $15.88M | 0.60% | +$15.88M |
| Aldeyra Therapeutics, Inc.(ALDX) | 9,275,851 | 4,051,631 | -5,224,220 | $53.34M | $15.52M | 0.58% | -$37.82M |
| Charles River Laboratories International, Inc.(CRL) | 0 | 100,000 | +100,000 | $0 | $15.17M | 0.57% | +$15.17M |
| Centessa Pharmaceuticals PlcADS | 3,040,395 | 1,146,935 | -1,893,460 | $43.72M | $15.07M | 0.57% | -$28.65M |
| Inhibrx Biosciences, Inc.(INBX) | 1,064,026 | 977,892 | -86,134 | $14.89M | $13.95M | 0.52% | -$931.2K |
| Adagio Medical Holdings, Inc.(ADGM) | 9,812,419 | 9,876,576 | +64,157 | $7.90M | $12.84M | 0.48% | +$4.94M |
| Nurix Therapeutics, Inc.(NRIX) | 297,553 | 1,096,985 | +799,432 | $3.53M | $12.49M | 0.47% | +$8.96M |
| Travere Therapeutics, Inc.(TVTX) | 0 | 834,252 | +834,252 | $0 | $12.35M | 0.46% | +$12.35M |
| Orchestra BioMed Holdings, Inc.(OBIO) | 4,592,556 | 4,592,556 | 0 | $19.66M | $12.31M | 0.46% | -$7.35M |
| Bright Minds Biosciences Inc.(DRUG) | 444,649 | 420,690 | -23,959 | $16.04M | $10.98M | 0.41% | -$5.05M |
| Inhibikase Therapeutics, Inc.(IKT) | 5,925,000 | 5,432,293 | -492,707 | $12.98M | $10.59M | 0.40% | -$2.38M |
| Viking Therapeutics, Inc.(VKTX) | 509,005 | 380,700 | -128,305 | $12.29M | $10.09M | 0.38% | -$2.20M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 270,000 | +270,000 | $0 | $9.82M | 0.37% | +$9.82M |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 210,106 | +210,106 | $0 | $9.17M | 0.34% | +$9.17M |
| Nautilus Biotechnology, Inc.(NAUT) | 12,594,211 | 12,594,211 | 0 | $10.84M | $9.13M | 0.34% | -$1.71M |
| Penumbra, Inc.(PEN) | 0 | 32,797 | +32,797 | $0 | $8.42M | 0.32% | +$8.42M |
| Crescent Biopharma, Inc.(CBIO) | 0 | 453,686 | +453,686 | $0 | $7.32M | 0.27% | +$7.32M |
| Aquestive Therapeutics Inc | 3,727,208 | 2,190,420 | -1,536,788 | $10.81M | $7.25M | 0.27% | -$3.56M |
| Janux Therapeutics, Inc.(JANX) | 970,412 | 292,686 | -677,726 | $26.20M | $6.76M | 0.25% | -$19.44M |
| Anteris Technologies Global Corp.(AVR) | 2,140,000 | 1,705,130 | -434,870 | $7.79M | $6.46M | 0.24% | -$1.33M |
| Xenon Pharmaceuticals Inc.(XENE) | 325,324 | 200,791 | -124,533 | $10.91M | $6.28M | 0.24% | -$4.63M |
| Viridian Therapeutics, Inc.(VRDN) | 659,662 | 447,507 | -212,155 | $8.89M | $6.26M | 0.23% | -$2.64M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 1,438,595 | +1,438,595 | $0 | $5.75M | 0.22% | +$5.75M |
| Septerna, Inc.(SEPN) | 0 | 541,450 | +541,450 | $0 | $5.72M | 0.21% | +$5.72M |
| Globus Medical, Inc.CL A(GMED) | 0 | 88,500 | +88,500 | $0 | $5.22M | 0.20% | +$5.22M |
| enVVeno Medical Corporation(NVNO) | 0 | 1,284,966 | +1,284,966 | $0 | $5.13M | 0.19% | +$5.13M |
| Helix Acquisition Corp IiCL A | 398,000 | 398,000 | 0 | $4.50M | $4.23M | 0.16% | -$270.6K |
| Opus Genetics, Inc.(IRD) | 4,325,000 | 4,325,000 | 0 | $4.25M | $4.07M | 0.15% | -$171.7K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 1,441,249 | 699,486 | -741,763 | $10.06M | $2.78M | 0.10% | -$7.28M |
| Lyra Therapeutics Inc | 0 | 255,150 | +255,150 | $0 | $2.29M | 0.09% | +$2.29M |
| Scpharmaceuticals Inc | 500,000 | 500,000 | 0 | $1.31M | $1.91M | 0.07% | +$590.0K |
| Athira Pharma Inc | 5,402,964 | 5,402,964 | 0 | $1.54M | $1.63M | 0.06% | +$92.4K |
| Rapt Therapeutics Inc | 0 | 183,890 | +183,890 | $0 | $1.47M | 0.06% | +$1.47M |
| Trinity Biotech plcADR(TRIB) | 0 | 1,790,000 | +1,790,000 | $0 | $1.16M | 0.04% | +$1.16M |
| Forte Biosciences Inc | 0 | 68,192 | +68,192 | $0 | $881.7K | 0.03% | +$881.7K |
| Avalo Therapeutics, Inc.(AVTX) | 520,000 | 139,667 | -380,333 | $4.17M | $696.9K | 0.03% | -$3.47M |
| Biodesix, Inc.(BDSX) | 2,173,880 | 2,173,880 | 0 | $1.36M | $613.0K | 0.02% | -$745.6K |
| Lexeo Therapeutics, Inc.(LXEO) | 139,835 | 139,835 | 0 | $485.2K | $562.1K | 0.02% | +$76.9K |
| Apyx Medical Corporation(APYX) | 150,000 | 150,000 | 0 | $205.5K | $337.5K | 0.01% | +$132.0K |
| KALA BIO, Inc.(KALA) | 277,610 | 55,227 | -222,383 | $1.59M | $262.9K | 0.01% | -$1.33M |
| Ensysce Biosciences, Inc.(ENSC) | 86,666 | 86,666 | 0 | $221.9K | $193.3K | 0.01% | -$28.6K |
| Revolution Medicines, Inc.W EXP 12 17 202(RVMD) | 250,000 | 250,000 | 0 | $9.5K | $65.7K | 0.00% | +$56.2K |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 166,666 | 166,666 | 0 | $5.0K | $3.0K | 0.00% | -$2.0K |
| Acrivon Therapeutics Inc | 5,360,858 | 0 | -5,360,858 | $10.88M | $0 | — | -$10.88M |
| Adaptive Biotechnologies Corporation(ADPT) | 930,972 | 0 | -930,972 | $6.92M | $0 | — | -$6.92M |
| Applied Therapeutics Inc | 860,000 | 0 | -860,000 | $420.5K | $0 | — | -$420.5K |
| argenx SEADR(ARGX) | 59,510 | 0 | -59,510 | $35.22M | $0 | — | -$35.22M |
| Cargo Therapeutics Inc | 2,431,085 | 0 | -2,431,085 | $9.89M | $0 | — | -$9.89M |
| Cullinan Therapeutics, Inc.(CGEM) | 80,100 | 0 | -80,100 | $606.4K | $0 | — | -$606.4K |
| Delcath Systems, Inc.(DCTH) | 462,422 | 0 | -462,422 | $5.89M | $0 | — | -$5.89M |
| DexCom, Inc.(DXCM) | 178,000 | 0 | -178,000 | $12.16M | $0 | — | -$12.16M |
| Disc Medicine, Inc.(IRON) | 150,000 | 0 | -150,000 | $7.45M | $0 | — | -$7.45M |
| EyePoint, Inc.(EYPT) | 1,537,274 | 0 | -1,537,274 | $8.33M | $0 | — | -$8.33M |
| Intra-Cellular Therapies Inc | 786,358 | 0 | -786,358 | $103.74M | $0 | — | -$103.74M |
| Iovance Biotherapeutics, Inc.(IOVA) | 12,711,788 | 0 | -12,711,788 | $42.33M | $0 | — | -$42.33M |
| Kestra Med Technologies LtdSHS SHS | 200,000 | 0 | -200,000 | $4.98M | $0 | — | -$4.98M |
| Lyra Therapeutics Inc | 12,757,562 | 0 | -12,757,562 | $1.61M | $0 | — | -$1.61M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 46,500 | 0 | -46,500 | $15.40M | $0 | — | -$15.40M |
| Mereo BioPharma Group plcADS(MREO) | 876,961 | 0 | -876,961 | $1.97M | $0 | — | -$1.97M |
| Nanobiotix S.A.ADS(NBTX) | 105,053 | 0 | -105,053 | $376.1K | $0 | — | -$376.1K |
| Ocular Therapeutix, Inc.(OCUL) | 915,775 | 0 | -915,775 | $6.71M | $0 | — | -$6.71M |